1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-19.76%
Both companies show declining cash positions (-19.76% vs CRVO's -20.15%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-19.76%
Similar yoy growth to CRVO's -20.15%. Walter Schloss would note comparable liquidity expansions. Examine capital usage strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-58.43%
Higher Other Current Assets Growth compared to CRVO's zero value, indicating worse performance.
-20.12%
Similar yoy growth to CRVO's -19.79%. Walter Schloss notes comparable short-term expansions. Investigate quality of these assets.
13.37%
Below half CRVO's -6.17%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.42%
Below half of CRVO's -0.25%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-19.74%
≥ 1.5x CRVO's -10.26%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
-6.57%
Less than half of CRVO's -58.06%. David Dodd sees a more disciplined AP approach or lower volume.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Exceeding 1.5x CRVO's -24.78%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-17.63%
Less than half of CRVO's -51.64%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.63%
50-75% of CRVO's -27.50%. Bruce Berkowitz notes a lower yoy liability increase.
0.13%
1.25-1.5x CRVO's 0.09%. Martin Whitman sees potential dilution risk vs. competitor approach.
-2.90%
0.5-0.75x CRVO's -4.26%. Martin Whitman is wary of weaker retention or lower profitability.
-5.63%
Higher AOCI Growth compared to CRVO's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-20.37%
≥ 1.5x CRVO's -8.14%. David Dodd sees stronger capital base growth than competitor.
-19.74%
≥ 1.5x CRVO's -10.26%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.76%
1.1-1.25x CRVO's 17.35%. Bill Ackman questions if net debt is increasing faster than competitor.
